Evidence map›Paper›PMID 36220266›Full record

ArticleMethods in enzymology2022

Engineering protein and DNA tools for creating DNA-dependent protein switches.

Harsimranjit Sekhon, Jeung-Hoi Ha, Stewart N Loh

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Harsimranjit SekhonDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, NY, United States.
Jeung-Hoi HaDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, NY, United States.
Stewart N LohDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, NY, United States. Electronic address: lohs@upstate.edu.
SUNY Upstate Medical University · US

Funding

Combining protein and DNA engineering to create bioswitchesR01GM148448 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI LOH, STEWART N · 2022 to 2025
$1.6M
Design of switchable proteins and enzymes.R01GM115762 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI LOH, STEWART N · 2015 to 2018
$1.3M
Molecular Devices for the Detection and Treatment of HCMV InfectionF30GM146428 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI Harsimranjit S Sekhon · 2022 to 2026
$268k
NIGMS NIH HHS F30 GM146428NIGMS NIH HHS R01 GM115762NIGMS NIH HHS R01 GM148448
6 · The paper itself

Abstract

Switchable proteins are capable of changing conformations from inactive (OFF) to active (ON) forms in response to inputs such as ligand binding, pH or temperature change, or light absorption. A particularly powerful class of protein switches, exemplified by the Cas nucleases of CRISPR systems, are activated by binding of specific DNA or RNA sequences. The mechanism by which oligonucleotide binding regulates biological activity is complex and highly specialized in the case of Cas enzymes, but recent advancements in protein and DNA engineering have made it possible to introduce this mode of control into other enzymes. This chapter highlights recent examples of protein switches that combine these two fields of engineering for the purpose of creating biosensors that detect pathogen and other genomic sequences. One protein engineering method-alternate frame folding-has the potential to convert many proteins into ligand-activated switches by inserting a binding protein (input domain) into an enzyme (output domain). The steps for doing so are illustrated using GCN4 as a DNA recognition domain and nanoluciferase as a luminescent reporter that changes color as a result of DNA binding. DNA engineering protocols are included for creating DNA tools (de novo designed hairpins and modified aptamers), that enable the biosensor to be activated by arbitrary DNA/RNA sequences and small molecules/proteins, respectively. These methodologies can be applied to other proteins to gain control of their functions by DNA binding.

Indexed as

Protein EngineeringProteinsDNALigandsOligonucleotidesDNALigandsOligonucleotidesProteinsAlternate frame foldingAptamerBiosensorBRETGCN4LuminescenceNanoluciferaseToehold-mediated strand displacement

Identifiers

PMID36220266
PMCPMC10314797
OpenAlexW4292682577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.